A prospective community based study for the evaluation of Rajapravartani Vati in the Management of Primary Dysmenorrhoea

Central Council for Research in Ayurvedic Sciences CCRAS0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•i.Young women of age 18 -25 years of scheduled Caste community
•ii.Self-reported history consistent with primary dysmenorrheal of moderate to severe nature (Mild: doesnâ??t interfere in normal activities, Moderate: slightly interferes in daily routines but can be managed by painkillers, Severe: markedly prevents daily life activities) with a self-reported menstrual cycle of averaging 21-35 days.
•iii.Willing and able to participate in the study (Written informed consent or assent).

•i.Irregular Cycles.
•ii.Cases of secondary Dysmenorrhea
•iii.Pain abdomen associated with excessive bleeding per vagina.
•iv.Presence of persistent pelvic pain throughout the menstrual cycle.
•v.Known case / diagnosis /h/o of leiomyoma of uterus, ovarian cyst, endometriosis.
•vi.Associated with clinically diagnosed pelvic inflammatory disease (PID),
•vii.Associated with any pre-diagnosed or clinically diagnosed systemic disorders likely to influence menstrual cycle.
•viii.Patients with Hb <= 7 gm %
•ix.History of malignancy of pelvic organs.
•x.Diagnosed cases Hypo/hyperthyroidism.
•xi.Woman using IUD / Oral Contraceptive Pills (OCP)
•xii.Patient co morbid with systemic diseases like diabetes mellitus, hypertension, cardiac/ Renal/ Pulmonary/ Hepatic disorders.
•xiii.Women who are planning to conceive in the next 6 months.
•xiv.Participation in other concomitant therapy for acute or chronic pain.

发起方

Central Council for Research in Ayurvedic Sciences CCRAS